The activist shareholder behind an attempt to replace the CEO of Athira Pharma has suspended his campaign. Billionaire Richard (Ric) Kayne nominated himself and an associate to the board in… Read More
The former head of clinical development and research at Athira Pharma criticized the company’s handling of an investigation that led to the resignation of longtime CEO Leen Kawas in October.… Read More
This week we highlighted the finalists for Health Innovation of the Year at the GeekWire Awards. The finalists showcase the strength of science and innovation in the Pacific Northwest. That… Read More
A billionaire investor of Athira Pharma is calling for the ouster of the Seattle company’s CEO and nominated himself and the former chief financial officer at Novartis for the board… Read More
Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered doctoral research images that helped to form the initial basis… Read More
The former CEO of Athira Pharma wrote a letter of contrition addressed to employees on Thursday, after resigning in the wake of a company investigation concluding she had altered images… Read More
Leen Kawas has formally resigned as CEO and president of Athira Pharma and is stepping off the board after an investigation found the biotech executive altered images in scientific papers… Read More
Athira Pharma is advancing its clinical trials in the wake of allegations of image manipulation in papers authored by its CEO, the company reported today in its second quarter financial… Read More
The lawsuits have begun. Barely a week after the CEO of Athira Pharma was placed on temporary leave after allegations of altered images in scientific papers she authored, three class… Read More
Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review “stemming from doctoral research Dr. Kawas conducted while at Washington… Read More
Seattle-based biotech company Athira Pharma announced a three-year grant totaling $15 million from the National Institute on Aging to support an upcoming clinical trial of a treatment that seeks to… Read More
More than 5 million Americans have Alzheimer’s disease, and the number is projected to rise to nearly 14 million by 2050. The disease is the sixth-leading cause of death in… Read More
Leen Kawas is truly a unicorn. The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the first woman to guide a company to an initial public… Read More
The number of tools and gadgets aimed at health has skyrocketed in the past few years. That technology can be a big help to those looking to improve their health,… Read More
Seattle-based M3 Biotechnology announced it has received a $1.4 million investment from the Alzheimer’s Drug Discovery Foundation, allowing it to begin preparing for clinical trials of its leading drug candidate. The… Read More
By now, we’re used to hearing complaints about the millennial generation. They’re cocky. They’re entitled. They’re never satisfied. They want a trophy just for showing up. But the flipside of… Read More